SMAD2 and hepatocellular carcinoma: Receptor-Smad2 and co-Smad4, like TβRI, were equally expressed in the different HCC cell lines, whereas Smad3 exhibited strikingly high mRNA and protein expression in HLE and HLF (Figure 2C, Figure S3).